Codes / ICD10CM / C84.14

C84.14 Sezary disease, lymph nodes of axilla and upper limb

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Sezary disease, lymph nodes of axilla and upper limb (ICD-10 Code: C84.14)

Summary

Sezary disease, lymph nodes of axilla and upper limb is a rare, aggressive form of cutaneous T-cell lymphoma characterized by the presence of malignant T-lymphocytes in the blood, skin, and lymph nodes. It is considered an advanced stage of mycosis fungoides and is distinguished by widespread skin involvement, severe itching, and the presence of abnormal cells (Sezary cells) in the bloodstream. The condition typically progresses slowly but can become systemic, affecting multiple organs over time.

Causes

The exact cause of Sezary disease, lymph nodes of axilla and upper limb is not fully understood. It is believed to involve genetic mutations in T-lymphocytes, which lead to uncontrolled growth and accumulation in the skin and blood. Environmental factors or chronic antigen stimulation may contribute to its development, though specific triggers remain unclear.

Risk Factors

  • Age: Most commonly diagnosed in adults over 50.
  • Male gender: Slightly higher prevalence in men.
  • Chronic skin conditions: History of eczema or other inflammatory skin disorders.
  • Immunosuppression: Weakened immune systems may increase risk.
  • Genetic predisposition: Family history of lymphoma or related disorders.

Symptoms

  • Widespread skin redness and scaling (erythroderma).
  • Severe, persistent itching (pruritus).
  • Enlarged lymph nodes in the axilla and upper limb (lymphadenopathy).
  • Abnormal cells (Sezary cells) in the bloodstream.

Diagnosis

Diagnosis involves a combination of clinical evaluation, skin biopsy, blood tests to detect Sezary cells, and imaging studies to assess lymph node involvement. A pathologist examines tissue samples for malignant T-lymphocytes, while flow cytometry or molecular testing may confirm the presence of abnormal cells. Staging helps determine the extent of disease, including lymph node involvement in the axilla and upper limb.

Treatment Options

Treatment may include skin-directed therapies (e.g., topical steroids, phototherapy), systemic therapies (e.g., chemotherapy, immunotherapy), and targeted agents. Lymph node involvement may require radiation or surgical evaluation. The choice of treatment depends on disease stage, patient health, and response to prior therapies.

Prognosis and Follow-Up

Prognosis varies based on disease stage and response to treatment. Regular follow-up is essential to monitor for progression or recurrence. Long-term management focuses on controlling symptoms and preventing systemic spread.

Complications

Complications may include infection due to skin breakdown, lymphedema from lymph node involvement, and systemic organ damage as the disease progresses. Severe itching and skin changes can significantly impact quality of life.

Lifestyle & Prevention

No specific prevention strategies exist. Managing chronic skin conditions and avoiding known irritants may help reduce symptoms. Maintaining overall health supports immune function.

When to Seek Professional Help

Seek care if you experience persistent skin redness, severe itching, or swollen lymph nodes in the axilla or upper limb. Early evaluation is crucial for accurate diagnosis and timely treatment.

Tips for Medical Coders

Document the specific lymph node location (axilla and upper limb) and confirm the diagnosis of Sezary disease. Ensure clinical correlation with biopsy and blood test results to support coding accuracy.

Medical Policies and Guidelines

Related policies from health plans

Istodax (romidepsin)
Book a walkthrough

C84.14 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.